Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Soon again around 185 $
On way to 35 $
OK - Many struggles with them today !!!!!!!!
Sorry,my bad about link - just only if you know something about -$SRNE To Announce Open Market Share Buy Back Program Early Next Week-
Sorrento Therapeutics Option Alert: Sep 18 $30 Calls Sweep (25) near the Ask: 500 @ $0.201 vs 4100 OI; Earnings 9/4 Before Open [est] Ref=$8.841
Benzinga
Do you know something about ?
Sorrento Therapeutics, Inc. $SRNE To Announce Open Market Share Buy Back Program Early Next Week
https://rumormurmursbuzz.blogspot.com/p/breaking.html
What should we see NEW here?
Do not rush to draw conclusions yet - be patient and wait for the press releases from the FDA or from them.Leaving aside the fact that all stocks related to this virus are falling, do not forget that investments in biotechnology stocks have a risk that each of us must assume.A drop in stock in the biotechnology sector does not necessarily mean that the company is run by some scammers.
Sorry,my bad.
Cramer's post about the article about Hindenburg and GRWG - it seems that the news is not a fake.
Jim Cramer
@jimcramer
I am not trying to get in the middle of things between Hindenburg and $GRWG but this is a classic raid by shorts to drive it down. The Chillman has seen this before as the shorts scare people out of their positions. No accounting irregularities mentioned in the report
Time and money lost with this scammer.
I don't think anyone has forgotten, but we also don't know how this research evolves, which is not normal in a company-investor relationship.I have been in this stock for a long time, I have held positions for almost two years but all this secrecy makes me feel uncomfortable.
Lack of management communication may be one of the reasons why shareholders lose confidence in the stock. We have no update on the evolution of this research, we are still waiting for the reason why CFO was fired and so on.This lack of communication is a little confusing.
The stock is on a strong upward trajectory driven by the good news of the mortgages industry and future reports that are expected to be explosive - probably this week we will see this stock around $ 30- $ 31. Or maybe above.
Thanks - I didn't know, but I will continue to search other sources if the news is confirmed.
Another company against the Hindenburg investigation into stock price manipulation statements-
https://www.prnewswire.com/news-releases/growgeneration-to-take-action-against-hindenburg-research-for-statements-intended-to-manipulate-stock-price-301116575.html
U.S. Drug Maker Sorrento Therapeutics recommended for 7.2 Billion Dollar Queensland Health contract.
Hannah Moore CovidNews 22 AUGUST 2020 7:23AM
A coronavirus vaccine being developed by U.S. drug maker Sorrento Therapeutics that has been shown to produce a strong immune response during early-stage clinical trials has been recommended for a 7.2 billion dollar contract with Queensland Health.
Dr. James Mueller chairman of the Queensland Health, Pandemic Response Advisory Board made the recommendation after a study conducted by Columbia University in the United States confirmed the vaccine generated both antibody and T-cell immune responses, which are hoped to be key to stopping an infection.
The fast pace of the vaccine effort has been cheered by officials around the world, however health experts warn that much remains unknown about the virus, and more testing is needed to understand how to offer people long-term protection against COVID-19, clinically known as SARS-CoV-2.
Scientists say immunity was detected in subjects for at least 56 days after getting the shot, but say further tests are needed to determine how long the immunity will last after that period. The experimental vaccine was shown to cause only minor side effects, including fever, fatigue and headaches.
The Phase 3 trials of the Sorrento Therapeutics vaccine are set to begin in Queensland by the end of August and will likely be expanded to other areas of Australia in the near future. The trial involves up to 30,000 volunteers who will help scientists understand whether the experimental vaccine can really prevent people from catching coronavirus and whether it is safe.
How long the Phase 3 trials will last depends on how high the transmission rate is in the test area. Scientists have said if the transmission rate remains high, they may be able to get enough data in a couple of months to see if the vaccine is working. But if transmission levels drop, it could take up to three months.
The experimental vaccine is made from a weakened form of the common cold virus that has been genetically modified to carry the coronavirus’s spike protein into the body, which is believed to trigger an immune response.
Countries around the world have also been developing their own experimental vaccines in a global race to stop the coronavirus pandemic, which has killed more than 600,000 people worldwide.
The World Health Organization lists 23 vaccines in human tests, including the Oxford one, and 140 more in lab studies.
Chinese researchers also published a study Monday in The Lancet of their own experimental coronavirus vaccine. The study showed modest positive results. However, some scientists have expressed concerns based on the early trials that the experimental vaccine might not work on all people because it uses a harmless virus at its core that many people already have immunity to.
China approved the use of its vaccine for its military in June.
Another drug maker, Pfizer and its German partner BioNTech also reported positive progress Monday on their vaccine candidate.
Good looking - congratulations
Sounds great - thank you - today I bought more
Why BofA Is Bullish On Nio's Battery Leasing Service
1:01 pm ET August 21, 2020 (Benzinga) Print
NIO Inc (NYSE: NIO) has launched a battery-as-a-service subscription model under a new entity, Battery Asset Co., in which it will hold a 25% equity stake.
The company will own battery assets and lease them to users who subscribe to the BaaS model, which will enable NIO to broaden its addressable market, according to BofA Securities.
The Nio Analyst: Ming Hsun Lee maintained a Buy rating on Nio with an $18 price target.
The Nio Takeaways: When purchasing an electric vehicle, users can take a monthly subscription on the battery pack under the BaaS model and get a discount on the original price, Lee said in a Thursday note. (See his track record here.)
The pricing under the BaaS model is competitive in the premium electric vehicle segment, the analyst said.
"The BaaS model would enable NIO users to enjoy lower initial purchase prices, flexible battery upgrade options (to 100kWh battery pack which will be launched later this year) and assurance of battery performance."
Nio's flexible sales model and battery solution could not only broaden its addressable market, but also strengthen its competitive position, enhance its brand equity and lower the burden on its balance sheet, according to BofA.
Does anyone know more about what is written in the following link?
https://www.arentfox.com/perspectives/alerts/covid-19-tests-no-longer-need-authorization-fda-marketing
Any price under $ 10 good to buy.
Two weeks ago I read something about $ 60
The best stock today - home sales good news for RKT
Options over today. From Monday possible start rally.
BOMMMMMMM - ON WAY TO 20 $
No, I don't think so - what we're discussing here doesn't influence the evolution of the market on this stock - it would be funnier if people believed that.
There is an application that can help you not get into desperate situations like the one you expose - it's called STOP MARKET - I advise you to use it.
Fear and greed are the biggest enemies of a trader - many of the investors in this stock are not here for his qualities which means long term positions - they are to speculate on a possible growth from which to get out as fast as they can and as soon as possible and with as much money as possible.Which honestly is not to be condemned - after all we are here to make money.
Soon at 110$
More gibberish.. upssssssss !!!!!!!!
To 20 $ or more .